Fertility warning
This medicine may affect fertility.
Leaflet EPIRUBICINA ACTAVIS 2mg / ml solution for injection / infusion
- Product code:
- W53325002
- Quantity:
- 1
- Indicated for:
- cancer
- Route of administration:
- injectable / infusion
- Substance:
- epirubicin (antineoplastic agent)
- ATC
- L01DB03 — Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Anthracyclines and related substances
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Epirubicin is a cytostatic medication used in the treatment of various types of cancer, such as breast cancer, bladder cancer, or sarcoma. It works by destroying cancer cells and stopping their multiplication. Administration is usually by intravenous infusion, under the strict supervision of a medical oncology team.
Treatment with epirubicin requires close monitoring, as it can affect healthy cells as well as cancer cells. It is important for patients to follow the treatment schedule and have regular tests to assess heart and blood function.
Side effects may include nausea, vomiting, hair loss, fatigue, decreased blood cell counts, or impaired heart function. In rare cases, severe allergic reactions or inflammation at the injection site may occur.
Epirubicin is an important medication in cancer treatment, but it requires constant medical supervision to manage side effects and ensure the effectiveness of therapy. Open communication with the doctor is essential throughout the treatment.
Treatment with epirubicin requires close monitoring, as it can affect healthy cells as well as cancer cells. It is important for patients to follow the treatment schedule and have regular tests to assess heart and blood function.
Side effects may include nausea, vomiting, hair loss, fatigue, decreased blood cell counts, or impaired heart function. In rare cases, severe allergic reactions or inflammation at the injection site may occur.
Epirubicin is an important medication in cancer treatment, but it requires constant medical supervision to manage side effects and ensure the effectiveness of therapy. Open communication with the doctor is essential throughout the treatment.
General data about EPIRUBICINA ACTAVIS 2mg / ml
- Substance:
- epirubicin
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W53325002
- Concentration:
- 2mg / ml
- Pharmaceutical form:
- solution for injection / infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Price:
- 57.40 RON
- Prescription status:
- S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Pharmaceutical forms available for epirubicin
Concentrations available for epirubicin
- 10mg
- 10mg/5ml
- 2mg/ml
- 50mg
- 50mg/25ml